FGF19 and hepatoblastoma: Importantly, our data indicate that silencing FGF19 signaling by FGF19 shRNAs, anti-FGF19 neutralizing antibody, or an FGF receptor kinase inhibitor, LY2874455, inhibits the growth of hepatoblastoma cells, suggesting that FGF19 is a critical autocrine growth factor for hepatoblastoma.